Characterization of the Rac-GAP (Rac-GTPase-activating protein) activity of beta2-chimaerin, a 'non-protein kinase C' phorbol ester receptor.
paper
Cited
Public
Unavailable
- Authors
- Caloca, Maria Jose; Wang, HongBin; Kazanietz, Marcelo G
- Year
- 2003
- Journal
- The Biochemical journal
- PMID
- 12877655
- DOI
- 10.1042/BJ20030727
- PMCID
- PMC1223697
The regulation and function of beta2-chimaerin, a novel receptor for the phorbol ester tumour promoters and the second messenger DAG (diacylglycerol), is largely unknown. As with PKC (protein kinase C) isoenzymes, phorbol esters bind to beta2-chimaerin with high affinity and promote its subcellular distribution. beta2-Chimaerin has GAP (GTPase-activating protein) activity for the small GTP-binding protein Rac1, but for not Cdc42 or RhoA. We show that acidic phospholipids enhanced its catalytic activity markedly in vitro, but the phorbol ester PMA had no effect. beta2-Chimaerin and other chimaerin isoforms decreased cellular levels of Rac-GTP markedly in COS-1 cells and impaired GTP loading on to Rac upon EGF (epidermal growth factor) receptor stimulation. Deletional and mutagenesis analysis determined that the beta2-chimaerin GAP domain is essential for this effect. Interestingly, PMA has a dual effect on Rac-GTP levels in COS-1 cells. PMA increased Rac-GTP levels in the absence of a PKC inhibitor, whereas under conditions in which PKC activity is inhibited, PMA markedly decreased Rac-GTP levels and potentiated the effect of beta2-chimaerin. Chimaerin isoforms co-localize at the plasma membrane with active Rac, and these results were substantiated by co-immunoprecipitation assays. In summary, the novel phorbol ester receptor beta2-chimaerin regulates the activity of the Rac GTPase through its GAP domain, leading to Rac inactivation. These results strongly emphasize the high complexity of DAG signalling due to the activation of PKC-independent pathways, and cast doubts regarding the selectivity of phorbol esters and DAG analogues as selective PKC activators.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of stimulant dependence. | 2021 | 34226506 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Diacylglycerol kinases: Molecular mechanism of cellular and physiological functions. | Kimura T et al. | β | 2026 | β |
| Cell migration signaling through the EGFR-VAV2-Rac1 pathway is sustained in endosomes. | Pinilla-Macua I et al. | β | 2025 | β |
| Ξ²2-Chimaerin, a GTPase-Activating Protein for Rac1, Is a Novel Regulator of Hepatic Insulin Signaling and Glucose Metabolism. | Carmona-Carmona CA et al. | β | 2024 | β |
| Genome-wide association study of stimulant dependence. | Cox J et al. | β | 2021 | β |
| Evaluation of active Rac1 levels in cancer cells: A case of misleading conclusions from immunofluorescence analysis. | Baker MJ et al. | β | 2020 | β |
| Identification of a truncated Ξ²1-chimaerin variant that inactivates nuclear Rac1. | Casado-Medrano V et al. | β | 2020 | β |
| New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein. | Sakane F et al. | β | 2020 | β |
| Optogenetic inhibition and activation of Rac and Rap1 using a modified iLID system | Elston RN et al. | β | 2020 | β |
| P-REX1-Independent, Calcium-Dependent RAC1 Hyperactivation in Prostate Cancer. | Baker MJ et al. | β | 2020 | β |
| SOX10-regulated promoter use defines isoform-specific gene expression in Schwann cells. | Fogarty EA et al. | β | 2020 | β |
| Post-Translational Modification and Subcellular Distribution of Rac1: An Update. | Abdrabou A et al. | β | 2018 | β |
| P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer. | Barrio-Real L et al. | β | 2018 | β |
| Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. | Isakov N | β | 2018 | β |
| Tumor promoter TPA activates Wnt/Ξ²-catenin signaling in a casein kinase 1-dependent manner. | Su Z et al. | β | 2018 | β |
| VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP Ξ²2-chimaerin. | Elaimy AL et al. | β | 2018 | β |
| CHN2 Promoter Methylation Change May Be Associated With Methamphetamine Dependence. | Hao L et al. | β | 2017 | β |
| The Rac GTPase in Cancer: From Old Concepts to New Paradigms. | Kazanietz MG et al. | β | 2017 | β |
| A new role of the Rac-GAP Ξ²2-chimaerin in cell adhesion reveals opposite functions in breast cancer initiation and tumor progression. | Casado-Medrano V et al. | β | 2016 | β |
| Characterization of a P-Rex1 gene signature in breast cancer cells. | Barrio-Real L et al. | β | 2016 | β |
| Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS. | Amin E et al. | β | 2016 | β |
| Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1Ξ±. | Lopez-Haber C et al. | β | 2016 | β |
| Ξ²3-chimaerin, a novel member of the chimaerin Rac-GAP family. | Zubeldia-Brenner L et al. | β | 2014 | β |
| Association of a novel polymorphism of the Ξ²2-chimaerin gene (CHN2) with smoking. | Barrio-Real L et al. | β | 2013 | β |
| Coordinated activation of the Rac-GAP Ξ²2-chimaerin by an atypical proline-rich domain and diacylglycerol. | Gutierrez-Uzquiza A et al. | β | 2013 | β |
| Rac1 pathway mediates stretch response in pulmonary alveolar epithelial cells. | Dipaolo BC et al. | β | 2013 | β |
| Catalytic activity and acyl-chain selectivity of diacylglycerol kinase Ι are modulated by residues in and near the lipoxygenase-like motif. | D'Souza K et al. | β | 2012 | β |
| Chimaerin suppresses Rac1 activation at the apical membrane to maintain the cyst structure. | Yagi S et al. | β | 2012 | β |
| Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilon. | Caino MC et al. | β | 2012 | β |
| Rac signaling in breast cancer: a tale of GEFs and GAPs. | Wertheimer E et al. | β | 2012 | β |
| Recent progress on type II diacylglycerol kinases: the physiological functions of diacylglycerol kinase Ξ΄, Ξ· and ΞΊ and their involvement in disease. | Sakai H et al. | β | 2012 | β |
| Control of synapse development and plasticity by Rho GTPase regulatory proteins. | Tolias KF et al. | β | 2011 | β |
| Rac-dependent doubling of HeLa cell area and impairment of cell migration and cell cycle by compounds from Iris germanica. | Halpert M et al. | β | 2011 | β |
| Rac GTPase-activating protein (Rac GAP) Ξ±1-Chimaerin undergoes proteasomal degradation and is stabilized by diacylglycerol signaling in neurons. | Marland JR et al. | β | 2011 | β |
| TLR2-dependent pathway of heterologous down-modulation for the CC chemokine receptors 1, 2, and 5 in human blood monocytes. | Fox JM et al. | β | 2011 | β |
| A novel cross-talk in diacylglycerol signaling: the Rac-GAP beta2-chimaerin is negatively regulated by protein kinase Cdelta-mediated phosphorylation. | Griner EM et al. | β | 2010 | β |
| Diacylglycerol kinases in the regulation of dendritic spines. | Kim K et al. | β | 2010 | β |
| Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurements. | Alford SK et al. | β | 2010 | β |
| Phosphatidic acid signaling regulation of Ras superfamily of small guanosine triphosphatases. | Zhang Y et al. | β | 2009 | β |
| Protein kinase C activators as synaptogenic and memory therapeutics. | Sun MK et al. | β | 2009 | β |
| Antiproliferative and survival properties of PMA in MCF-7 breast cancer cell. | Fortino V et al. | β | 2008 | β |
| Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. | Yang C et al. | β | 2008 | β |
| Phorbol ester and hydrogen peroxide synergistically induce the interaction of diacylglycerol kinase gamma with the Src homology 2 and C1 domains of beta2-chimaerin. | Yasuda S et al. | β | 2008 | β |
| Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion. | Fournier AK et al. | β | 2008 | β |
| alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini. | Friedland JC et al. | β | 2007 | β |
| Cadherins, RhoA, and Rac1 are differentially required for stretch-mediated proliferation in endothelial versus smooth muscle cells. | Liu WF et al. | β | 2007 | β |
| Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac. | Yang C et al. | β | 2007 | β |
| Diacylglycerol kinase gamma interacts with and activates beta2-chimaerin, a Rac-specific GAP, in response to epidermal growth factor. | Yasuda S et al. | β | 2007 | β |
| Diacylglycerol kinases: why so many of them? | Sakane F et al. | β | 2007 | β |
| Downregulation of Rap1GAP contributes to Ras transformation. | Tsygankova OM et al. | β | 2007 | β |
| EphA4-dependent axon guidance is mediated by the RacGAP alpha2-chimaerin. | Wegmeyer H et al. | β | 2007 | β |
| GEFs and GAPs: critical elements in the control of small G proteins. | Bos JL et al. | β | 2007 | β |
| Monocyte p110alpha phosphatidylinositol 3-kinase regulates phagocytosis, the phagocyte oxidase, and cytokine production. | Lee JS et al. | β | 2007 | β |
| Phospholipase C gamma negatively regulates Rac/Cdc42 activation in antigen-stimulated mast cells. | El-Sibai M et al. | β | 2007 | β |
| Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity. | Tani M et al. | β | 2007 | β |
| Tyrosine phosphorylation of beta2-chimaerin by Src-family kinase negatively regulates its Rac-specific GAP activity. | Kai M et al. | β | 2007 | β |
| Beta2-chimaerin provides a diacylglycerol-dependent mechanism for regulation of adhesion and chemotaxis of T cells. | Siliceo M et al. | β | 2006 | β |
| Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both. | Cohen G et al. | β | 2006 | β |
| Phospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signaling. | Wang H et al. | β | 2006 | β |
| Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC). | Zhang G et al. | β | 2006 | β |
| The diacylglycerol-binding protein alpha1-chimaerin regulates dendritic morphology. | Buttery P et al. | β | 2006 | β |
| The lipid second messenger diacylglycerol as a negative regulator of Rac signalling. | Wang H et al. | β | 2006 | β |
| The zebrafish homologue of mammalian chimerin Rac-GAPs is implicated in epiboly progression during development. | Leskow FC et al. | β | 2006 | β |
| A comprehensive pathway map of epidermal growth factor receptor signaling. | Oda K et al. | β | 2005 | β |
| A missense polymorphism (H204R) of a Rho GTPase-activating protein, the chimerin 2 gene, is associated with schizophrenia in men. | Hashimoto R et al. | β | 2005 | β |
| C1, see them all. | Hall C et al. | β | 2005 | β |
| Dual effects of bryostatin-1 on spatial memory and depression. | Sun MK et al. | β | 2005 | β |
| Nuclear envelope assembly is promoted by phosphoinositide-specific phospholipase C with selective recruitment of phosphatidylinositol-enriched membranes. | Byrne RD et al. | β | 2005 | β |
| Oscillatory ROP GTPase activation leads the oscillatory polarized growth of pollen tubes. | Hwang JU et al. | β | 2005 | β |
| PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors. | Oliva JL et al. | β | 2005 | β |
| Rac-GAP-dependent inhibition of breast cancer cell proliferation by {beta}2-chimerin. | Yang C et al. | β | 2005 | β |
| Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications. | Kazanietz MG | β | 2005 | β |
| Diacylglycerol kinase gamma serves as an upstream suppressor of Rac1 and lamellipodium formation. | Tsushima S et al. | β | 2004 | β |
| Divergent and convergent signaling by the diacylglycerol second messenger pathway in mammals. | Brose N et al. | β | 2004 | β |
| Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin. | Canagarajah B et al. | β | 2004 | β |
| Divergence and complexities in DAG signaling: looking beyond PKC. | Yang C et al. | β | 2003 | β |